Faderl, S., Ferrajoli, A., Wierda, W., O'Brien, S., Lerner, S., & Keating, M. J. (2010). Alemtuzumab by Continuous Intravenous Infusion Followed by Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence. Cancer.
Chicago ZitierstilFaderl, Stefan, Alessandra Ferrajoli, William Wierda, Susan O'Brien, Susan Lerner, und Michael J. Keating. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.
MLA ZitierstilFaderl, Stefan, et al. "Alemtuzumab By Continuous Intravenous Infusion Followed By Subcutaneous Injection Plus Rituximab in the Treatment of Patients With Chronic Lymphocytic Leukemia Recurrence." Cancer 2010.